The Team

Sam Zaidspiner
Sam Zaidspiner Chief Executive Officer
Sam is a co-founder of MedWatch Technologies and a MedTech executive with over 35 years of experience launching medical devices and consumer health products. He has led the development, regulatory clearance. And global commercialization of dozens of innovative technologies, delivering successful outcomes for both startups and established market leaders. Most recently, Sam served as COO at Irrimax, where he directed the development and 510 (k) clearance of

Irrisept®, a breakthrough Class II medical device for reducing surgical site
infections. Under his leadership, the company grew from early stage to market leader with broad U.S. and international distribution, culminating in its acquisition by ArchiMed in late
2024.

Sam is recognized for translating complex technology into scalable, commercially viable products, with particular depth in regulatory strategy, team building, and forging the strategic partnerships that bring breakthrough innovations to market.

Show More Show Less
Linkedin
Bruce Matichuk
Bruce Matichuk, MSc, MBA CTO - Advanced Research
Bruce is a co-founder of MedWatch Technologies and a seasoned AI and software engineering executive with over two decades of experience building intelligent systems that scale. He has served as CTO for multiple AI-based companies and holds several patents spanning intelligent integration systems and automated reasoning, with largescale deployments at IBM, Apple, Lockheed Martin, Liberty Mutual, United Airlines, and Hallmark.

Previously, Bruce co-founded Health Gauge, a health information platform integrating wearable technology and AI analytics. His current research focuses on neurosymbolic AI, reinforcement learning, and agentic orchestration — areas central to the next generation of human-AI collaboration in healthcare. He holds an MSc in Computing Science from the University of Alberta and an MBA in Health Administration from the Jack Welch Management Institute at Strayer University, and will complete his PhD in Artificial Intelligence in 2026.

Show More Show Less
Linkedin
Diseño sin título - 2026-03-11T111033.242
Masoud Baghelani, PhD CTO - Sensor
Dr. Baghelani is a co-founder of MedWatch Technologies and an electrical and computer engineer whose career has centered on developing microwave sensor technology for industrial and biomedical applications. He holds a PhD from Sahand University of Technology and spent nearly a decade as a faculty member at Ilam University in Iran, rising to Associate Professor while founding KES (Knowledge-Based Engineering Solutions), a company recognized as

Best Technological Startup in Western Iran in 2016 and 2017 and honored by the Iranian Minister of Science in 2018.
In pursuit of new frontiers in non-invasive health monitoring, Masoud completed a postdoctoral fellowship at the University of Alberta in collaboration with the Alberta
Diabetes Institute, where he focused on microwave-based sensing for glucose and metabolic monitoring. He was appointed Adjunct Professor in the Department of Electrical and Computer Engineering at the University of Alberta in 2021, and has since served as
Principal Investigator or Co-PI on four research grants.

Masoud co-developed a provisional patent for non-invasive glucose monitoring technology alongside Professor Peter Light, which lead to the co-founding of MedWatch Technologies.

He has published over 60 peer-reviewed papers and holds multiple patents. Masoud was named a Senior Member of IEEE in 2021.

Show More Show Less
Linkedin
Diseño sin título - 2026-03-11T111957.247
Virender Ahluwalia Chief Financial Officer
Virender is a finance and operations executive with over 15 years of experience across high-growth startups, public companies, private organizations, and nonprofits. His background spans the full organizational lifecycle — from early-stage and pre-IPO environments to Fortune 500 companies and turnaround situations. Virender brings particular expertise in building and optimizing financial infrastructure in complex

multi-entity environments, raising capital, and developing high-performing teams.
At MedWatch Technologies, he oversees all financial strategy and operations, ensuring the
company is structured for sustainable growth as it moves toward commercialization of its non-invasive glucose monitoring platform.

Show More Show Less
Linkedin
Diseño sin título - 2026-03-11T113336.181
Dr. Peter Light, PhD Chief Science Officer
Dr. Light is a co-founder of MedWatch Technologies and a pharmacologist and diabetes researcher whose work spans cellular excitability in the heart and endocrine pancreas, with a particular focus on the mechanisms underlying insulin secretion and cardiac function. He served as Director of the Alberta Diabetes Institute from 2010 to 2021, one of Canada's foremost diabetes research centers, and currently serves as Interim Chair of the Department of

Pharmacology at the University of Alberta. Over the past seven years, Dr. Light has led a multidisciplinary effort to develop the world’s first non-invasive wearable glucose sensor, collaborating with engineers and AI specialists to bring the technology from concept to in-human testing. Dr. Light is a Fellow of the Canadian Physiological Society and has been recognized with
awards from the Heart and Stroke Foundation of Canada, Diabetes Canada, and the Canadian Institutes of Health Research.

He holds the Dr. Charles A. Allard Chair in Diabetes Research and regularly reviews manuscripts for top-ranked journals and grants for national and international funding bodies.

Show More Show Less
Linkedin
Geraldine-Cunniffe-Conlon-e1695228251762
Geraldine Cunniffe-Conlon, MD, MSc, MBA Chief Medical Officer
Dr. Cunniffe-Conlon is a physician and executive with more than 20 years of international experience as an Ophthalmic and Oculofacial Plastic Surgeon, registered with medical regulatory bodies in both the UK and Ireland. She has authored 14 peer-reviewed papers and is a member of numerous international medical societies. Her work at the intersection of medicine and technology includes

experience in R&D, data science, IP health-related challenges and hackathons in London’s University College and School of Economics and pitch events across Los Angeles.

She has experience in R&D and data science for medical device and digital health technologies. She has also worked in the IP and regulatory environment since commencing her executive MBA in 2013. She has been active in the international start-up community as ambassador, mentor and meeting coordinator for Google Start-up Grind.

Dr. Cunniffe-Conlon has a keen interest in AI-driven data discovery and analytics, having studied AI at the Sloane School of Management, MIT. She holds a range of academic and industry qualifications including a Bachelor of Medicine from the National University of Ireland, Galway, an MSc and MBA from University College and Trinity College Dublin respectively.

Show More Show Less
Linkedin
Andres Tovar
Andres Tovar VP, Product Development & Manufacturing
Andres is a product development and operations leader with over 20 years of experience bringing medical devices and complex engineered products to market. His expertise spans new product introduction, project management, manufacturing engineering, and commercial operations across organizations ranging from startups to large corporations. Andres has spent 19 years in the

MedTech industry, including roles at Johnson & Johnson, where he led product launches and supported global manufacturing operations. He has
managed product development teams in Canada and manufacturing operations in Mexico and the U.S. for a mid-size defense contractor, demonstrating the cross-functional and cross-border experience that MedWatch’s commercialization phase demands.

Andres holds a BS in Mechanical Engineering from Florida Atlantic University and an MBA from Indiana University’s Kelley School of Business, with a focus on strategy, marketing, and entrepreneurship.

Show More Show Less
Linkedin
Diseño sin título - 2026-03-11T120210.542
Gabriela Cordero Director of Product Management
Gabriela is a product leader with more than 10 years of experience in product management, strategy, and partnerships across the digital health, fitness, and wellness industries. Prior to MedWatch, Gabriela served as Director of Product and Design at SweatWorks, partnering with early-stage startups and Fortune 500 companies on new product

launches — including bringing Nix Biosensors’ hydration biosensor to market. Earlier in her career, she led new product development at Life Fitness, spearheading hardware and software integrations for the company’s group training category.

Gabriela joined MedWatch Technologies to lead product strategy and commercialization of the company’s biosensing wearable platform. She holds a Bachelor of Science in Business Administration from the University of Maryland.

Show More Show Less
Linkedin